[go: up one dir, main page]

AU7126998A - Anti-influenza compositions supplemented with neuraminidase - Google Patents

Anti-influenza compositions supplemented with neuraminidase

Info

Publication number
AU7126998A
AU7126998A AU71269/98A AU7126998A AU7126998A AU 7126998 A AU7126998 A AU 7126998A AU 71269/98 A AU71269/98 A AU 71269/98A AU 7126998 A AU7126998 A AU 7126998A AU 7126998 A AU7126998 A AU 7126998A
Authority
AU
Australia
Prior art keywords
neuraminidase
influenza compositions
compositions supplemented
supplemented
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71269/98A
Inventor
Bert E. Johansson
Edwin D. Kilbourne
James T. Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
Original Assignee
Connaught Laboratories Ltd
Connaught Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd, Connaught Laboratories Inc filed Critical Connaught Laboratories Ltd
Publication of AU7126998A publication Critical patent/AU7126998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU71269/98A 1997-04-16 1998-04-16 Anti-influenza compositions supplemented with neuraminidase Abandoned AU7126998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84351997A 1997-04-16 1997-04-16
US08843519 1997-04-16
PCT/US1998/007705 WO1998046262A1 (en) 1997-04-16 1998-04-16 Anti-influenza compositions supplemented with neuraminidase

Publications (1)

Publication Number Publication Date
AU7126998A true AU7126998A (en) 1998-11-11

Family

ID=25290246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71269/98A Abandoned AU7126998A (en) 1997-04-16 1998-04-16 Anti-influenza compositions supplemented with neuraminidase

Country Status (2)

Country Link
AU (1) AU7126998A (en)
WO (1) WO1998046262A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136722A1 (en) * 1997-06-18 2002-09-26 Heath Andrew William Vaccination method
CN102755645A (en) 2005-11-04 2012-10-31 诺华疫苗和诊断有限公司 Influenza vaccines with reduced amount of emulsion adjuvant
EP1951302A2 (en) 2005-11-04 2008-08-06 Novartis Vaccines and Diagnostics S.r.l. Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
NZ568211A (en) 2005-11-04 2011-11-25 Novartis Vaccines & Diagnostic Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
EP1945252B1 (en) 2005-11-04 2013-05-29 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising purified surface antigens prepared from influenza viruses grown in cell culture, adjuvanted with squalene
JP6087041B2 (en) 2006-01-27 2017-03-08 ノバルティス アーゲー Influenza virus vaccine containing hemagglutinin and matrix protein
TWI477602B (en) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
US20100068223A1 (en) 2006-03-24 2010-03-18 Hanno Scheffczik Storage of Influenza Vaccines Without Refrigeration
GB0614460D0 (en) 2006-07-20 2006-08-30 Novartis Ag Vaccines
GB0810305D0 (en) 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
CA2763816A1 (en) 2009-04-27 2010-11-04 Novartis Ag Adjuvanted vaccines for protecting against influenza
EP2435066B1 (en) 2009-05-29 2013-11-20 Novartis AG Assays for influenza virus hemagglutinins
WO2011030218A1 (en) 2009-09-10 2011-03-17 Novartis Ag Combination vaccines against respiratory tract diseases
BR112012030616A2 (en) 2010-06-01 2017-03-01 Novartis Ag concentration of freeze-dried vaccine antigens.
HUE051711T2 (en) 2010-06-01 2021-03-29 Seqirus Uk Ltd Concentration of influenza vaccine antigens without lyophilization
ES2531577T3 (en) 2010-08-20 2015-03-17 Novartis Ag Needle sets for administration of soluble flu vaccine
EP2768528A1 (en) 2011-10-20 2014-08-27 Novartis AG Adjuvanted influenza b virus vaccines for pediatric priming
ES2564138T3 (en) 2011-12-12 2016-03-18 Novartis Ag Influenza Virus Hemagglutinin Assay
EP2900259B1 (en) * 2012-09-28 2020-04-15 Kline, Ellis Glycosidase regimen for treatment of infectious disease
GB201218195D0 (en) 2012-10-10 2012-11-21 Istituto Zooprofilattico Sperimentale Delle Venezie Composition
EP3313439A2 (en) 2015-06-26 2018-05-02 Seqirus UK Limited Antigenically matched influenza vaccines
KR102576962B1 (en) 2015-07-07 2023-09-11 세퀴러스 유케이 리미티드 Influenza efficacy assay
JP2019511255A (en) 2016-01-11 2019-04-25 バーンダリ,インク. Microneedle composition and method of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667245B1 (en) * 1990-10-01 1992-11-06 Rhone Merieux VACCINE ASSOCIATION AGAINST INFECTIOUS PATHOGENS.
FR2671974A1 (en) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc INFLUENZA VACCINE COMPOSITION WITH SYNERGISTIC EFFECT, CONTAINING AS AN ADDITIVE TO INFLUENZA VIRUS CORE.
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines

Also Published As

Publication number Publication date
WO1998046262A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
AU7126998A (en) Anti-influenza compositions supplemented with neuraminidase
AU8684498A (en) Self-riveting fastening element
EP0926468B8 (en) Display
AU5641098A (en) Sealant compositions
AU4492197A (en) Shaped adhesives
GB9722736D0 (en) Adhesive compositions
AU4765997A (en) Clinch-type fastener member
AU7219798A (en) Adhesive composition
AU1532899A (en) Self standing merchandiser
AU5254098A (en) Conditioning shampoo compositions
AU1242399A (en) Nose sprayer
AU9373498A (en) Fastener element arrangement
AU7474198A (en) Dispenser-applicator assembly
AU8747998A (en) Anti-inflammatory agent
AUPO779697A0 (en) Advertising using the internet
EP1002847B8 (en) Self-adhesive composition
AU5575398A (en) Hairdye compositions
AU8673598A (en) Neuraminidase inhibitors
EP0903415A3 (en) Structure expansée
AU5032298A (en) Coating compositions
AU8351198A (en) Improvements relating to connection devices
AU5622498A (en) V-nail fastener
AU6304898A (en) Fasteners
AU8650998A (en) Female push-on fastening element
AUPP053197A0 (en) Compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase